Article about Nusantara vaccine published in an online international journal

Terawan dan LBP
Coordinating Maritime Affairs and Investment Minister Luhut Binsar Pandjaitan allowed his blood to be taken as sample for the development of Nusantara Covid-19 vaccine. (Source: detik)

Jakarta, IO – Former Indonesian Health Minister Terawan Agus Putranto announced a journal article on Nusantara vaccine titled “Dendritic cell vaccine as a potential strategy to end the Covid-19 pandemic. Why should it be Ex Vivo?” has been published on an online international journal on May 26, 2022.

“I am very grateful that international journal article related to the Nusantara vaccine has been published. Everyone can access and learn about the advancement of health science,” Terawan was quoted as saying by CNN Indonesia on Friday (27/5).

“The journal on Nusantara vaccines is published by Taylor and Francis Online, which is a digital version of the Taylor & Francis Group, a British multinational company that publishes books and academic journals,” Terawan added.

The Nusantara vaccine was developed using a dendritic cell where each person’s blood sample is taken and then exposed to a vaccine kit made from dendritic cells. Then the cells that have recognized the antigen will be incubated for 3-7 days.